Dawn joined BresMed in 2010 and became a Board member in 2019. Before joining BresMed, Dawn worked for a transport economics consultancy, after gaining an MMath degree. She completed an MSc in health economics and decision modelling after starting at BresMed. She has experience in a number of disease areas and project types, and currently specializes in oncology modelling (in immuno-oncology in particular), early product assessment, health technology assessment (HTA) strategy, complex decision problems, models with complex statistical needs, end-to-end modelling solutions using R/R-SHINY and anything else “a bit weird and wonderful”. Dawn takes an advisory role on projects, with occasional hands-on technical modelling. Her role as Chief Scientific Officer focusses on achieving and maintaining BresMed’s position at the leading edge of health economics and outcomes research (HEOR), identifying trends within the industry and new types of work and methods for BresMed.
In her spare time, Dawn enjoys live music and science fiction and fantasy – particularly Dr Who.
What Dawn says about BresMed: “The team at BresMed let me take responsibility for the fun stuff – figuring out how we can use and operationalize new techniques in the market and solve the really complex problems.”
2019-Present Chief Scientific Officer BresMed
2018-2019 Frontiers Group BresMed
2014-2018 Head of Health Economics Analysis team BresMed
2010-2014 Health Economics roles BresMed
2005-2010 Senior Consultant AECOM
Current research areas include: